Literature DB >> 2786818

Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series.

F Rodrîguez-Panadero1, F Borderas Naranjo, J López Mejîas.   

Abstract

We examined the post-mortem records of 191 patients who had one or more malignant tumours (196 neoplasms in total). We found 55 cases with pleural metastases (28%) and 30 of these presented pleural effusions (15% of the total number of neoplasms). The visceral pleural was involved in all 24 cases of lung cancer with pleural metastasis and in 27 out of 31 of those of other origins. The parietal pleura was affected in 16 out of 24 cases of the lung tumours and in 15 out of 31 of those of other origins. There were no cases in which only the parietal layer of the pleura was involved, with the only exception of neighbouring tumours. We found neoplastic vascular invasion in 43 out of 55 cases, retrograde lymphatic spread from the mediastinum in two cases, and direct pleural involvement from a neighbouring tumour in the remaining. We conclude that malignant pleural implantation fundamentally arises from the spread of tumour emboli to the lungs and the visceral pleura, with secondary seedings to the parietal pleura. Therefore, this phenomenon leads to the usual finding of lower involvement of parietal pleura as compared to the visceral pleura in our series.

Entities:  

Mesh:

Year:  1989        PMID: 2786818

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.

Authors:  Rahul Bhatnagar; Ramon Luengo-Fernandez; Brennan C Kahan; Najib M Rahman; Robert F Miller; Nick A Maskell
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

3.  Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy.

Authors:  Shu-Hong Sheng; Hui-Li Zhu
Journal:  Clin Transl Oncol       Date:  2013-08-02       Impact factor: 3.405

4.  Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.

Authors:  David E Ost; Jiangong Niu; Hui Zhao; Horiana B Grosu; Sharon H Giordano
Journal:  Chest       Date:  2017-08-31       Impact factor: 9.410

Review 5.  Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions?

Authors:  Giles Dixon; Duneesha de Fonseka; Nick Maskell
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

6.  Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer.

Authors:  Bulent Ozcakar; Carlos H Martinez; Rodolfo C Morice; Georgie A Eapen; David Ost; Mona G Sarkiss; Hsienchang T Chiu; Carlos A Jimenez
Journal:  J Cardiothorac Surg       Date:  2010-08-18       Impact factor: 1.637

Review 7.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

Review 8.  The treatment of pleural carcinosis with malignant pleural effusion.

Authors:  Michael Ried; Hans-Stefan Hofmann
Journal:  Dtsch Arztebl Int       Date:  2013-05       Impact factor: 5.594

9.  Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion.

Authors:  Rogier C Boshuizen; Andrew D Vincent; Michel M van den Heuvel
Journal:  Support Care Cancer       Date:  2013-07-11       Impact factor: 3.603

10.  Homocysteine: new tumor marker in pleural fluid.

Authors:  Jose D Santotoribio; Consuelo Cañavate-Solano; Angela Garcia-de la Torre; Luis Del Valle-Vazquez; Francisco Arce-Matute; Juan F Cuadros-Muñoz; Maria J Sanchez del Pino; Manuel J Bandez-Ruiz; Carmen Piñuela-Rojas; Santiago Perez-Ramos
Journal:  Tumour Biol       Date:  2015-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.